Assign modules on offcanvas module position to make them visible in the sidebar.


eye drops 0.025%, 10 ml

Dispensing conditions: NO PRESCRIPTION 


  • reduce swelling, redness, inflammation, lacrimation;

  • it is indicated for allergic conjunctivitis, conjunctivitis of non-infectious etiology (smoke, dust, wind and sun exposure, chlorinated water, artificial light), congestion and edema of the conjunctiva;

  • the effect occurs in 15 minutes and lasts for 6-8 hours.

dwldDownload instructions for use


1 ml of the product contains:

  • active substance - oxymetazoline hydrochloride - 0.25 mg;
  • excipients: benzalkonium chloride (as 10 % solution), sodium chloride, sodium dihydrophosphate dihydrate, dodecahydrate phosphate dihydrate, water for injection.

Pharmaceutical form

Eye drops 0.025%, 10 ml.

Pharmacotherapeutic group

Medications for eye diseases. Decongestants and anti-allergy drugs. Sympathomimetics used as decongestants. Oxymetazoline

ATC code S01GA04


  • allergic conjunctivitis;
  • сonjunctivitis of non-infectious etiology (smoke, dust, wind and sun exposure, chlorinated water, artificial light);
  • congestion and swelling of the conjunctiva.


  • hypersensitivity to the components of the product;
  • closed angle glaucoma;
  • arrhythmias;
  • arterial hypertension;
  • chronic heart failure;
  • chronic renal failure;
  • pronounced atherosclerosis;
  • diabetes mellitus;
  • thyrotoxicosis, hyperthyroidism;
  • prostatic hyperplasia;
  • concomitant use of monoamine oxidase inhibitors and a period of up to 14 days after the end of their use;
  • pheochromacytoma;
  • porphyria
  • children under 8 years of age;
  • pregnancy and lactation period.

Posology and method of administration


Adults and children over 8 years of age: 1-2 drops of the product in each eye 3-4 times a day into the conjunctival sac.

The course of treatment is not more than 3 days.

Remove contact lenses before applying the product and wait at least 15 minutes after the product has been instilled.

Make sure that the tip of the dropper bottle does not come into contact with other objects or surfaces when instilling.

Close the dropper bottle tightly with the cap after instillation!

Adverse reactions

The product is usually well-tolerated.


  • irritation of the conjunctiva and surrounding tissues;
  • mydriasis;
  • paresis of accommodation;
  • eyelid retraction.


  • iritis is possible;
  • anxiety;
  • sleep disturbance;
  • fatigue;
  • headache;
  • dizziness;
  • nausea;
  • hypertension;
  • tachycardia.


Symptoms: irritation and dryness of the conjunctiva, mydriasis, increased intraocular pressure.

Treatment: flush eyes with running water, then - symptomatic therapy.

Use during pregnancy or breastfeeding

Not approved for use.

Pediatric population

Approved for children over 8 years of age.

Special warnings

You should not independently exceed the recommended doses and use the product for more than 3 days.

Use with caution in coronary heart disease (CHD).

Since benzalkonium chloride in the product discolors soft contact lenses, you should refrain from wearing soft contact lenses during treatment!

Given the side effects of Oxyvin-DF, caution should be exercised when driving a vehicle or operating potentially dangerous machinery.

Presentation and package

10 ml of the product in plastic dropper bottles, sealed with tamper-proof caps, or in 10 ml plastic dropper bottles, sealed with caps. Each bottle has a label. One bottle is with instruction for use in the state and Russian language are placed in a carton pack.

Storage conditions

Store in a place protected from light, at a temperature below 250С.

Keep out of the reach of children.

Shelf life

3 years.

The period of use of the product after opening the bottle is 28 days.


"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan, tel.: (727) 253-03-88.

Marketing authorization holder

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan.

Name, address, contact information of the organization accepting claims (proposals) against quality of products from consumers in the territory of the Republic of Kazakhstan, which is responsible for post-authorization safety surveillance of the medicine:

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan,

Tel./Fax: (727) 253-07-07, 253-03-88, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Ask a question about this product: